[Ureteral metastasis of prostatic adenocarcinoma: case report and literature review]

Q Manach; V Phé; J Parra; R Renard-Penna; E Compérat; M-O Bitker

doi:10.1016/j.purol.2013.05.003

[Ureteral metastasis of prostatic adenocarcinoma: case report and literature review]

Prog Urol. 2013 Dec;23(16):1443-8. doi: 10.1016/j.purol.2013.05.003. Epub 2013 Jun 10.

[Article in French]

Authors

Q Manach¹, V Phé, J Parra, R Renard-Penna, E Compérat, M-O Bitker

Affiliation

¹ Service d'urologie, université Paris VI, université Pierre-et-Marie-Curie, CHU Pitié-Salpêtrière, Assistance publique-Hôpitaux de Paris, 47-83, boulevard de l'Hôpital, 75651 Paris cedex 13, France.

PMID: 24274950
DOI: 10.1016/j.purol.2013.05.003

Abstract

Ureteral metastases of prostatic adenocarcinoma are very rare. We report the case of a 66-year-old man with a right ureteral metastasis of prostate cancer. Only 10 cases have been reported in the literature these last 30 years. Most patients had a multimetastatic prostate cancer. Local treatment is not standardized. Hormonotherapy seems to be the most appropriate treatment in first intention.

Keywords: Adénocarcinome prostatique; Métastase urétérale; Obstruction urétérale; Prostatic adenocarcinoma; Ureteral metastasis; Ureteral obstruction.

Publication types

Case Reports
English Abstract
Review

MeSH terms

Adenocarcinoma / blood
Adenocarcinoma / secondary*
Adenocarcinoma / therapy
Aged
Androgen Antagonists / therapeutic use
Antineoplastic Agents, Hormonal / therapeutic use
Biomarkers, Tumor / blood*
Drug Therapy, Combination
Humans
Male
Prostate-Specific Antigen / blood*
Prostatic Neoplasms / blood
Prostatic Neoplasms / pathology*
Prostatic Neoplasms / therapy
Treatment Outcome
Ureteral Neoplasms / blood
Ureteral Neoplasms / secondary*
Ureteral Neoplasms / therapy
Urologic Surgical Procedures

Substances

Androgen Antagonists
Antineoplastic Agents, Hormonal
Biomarkers, Tumor
Prostate-Specific Antigen